Oncotelic Therapeutics, Inc. SEC filings OTLC
Oncotelic Therapeutics, Inc. has 1,007 filings in SEC EDGAR's recent list, going back to Jul 19, 2005. Its latest annual report, Form 10-K, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 26, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-K | Annual report | Apr 15, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Apr 15, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Apr 12, 2024 | Dec 31, 2023 |
| 10-K/A | Amended annual report | Apr 20, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Apr 14, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Apr 15, 2022 | Dec 31, 2021 |
| 10-K | Annual report | Apr 15, 2021 | Dec 31, 2020 |
| 10-K/A | Amended annual report | May 20, 2020 | Dec 31, 2019 |
| 10-K | Annual report | May 14, 2020 | Dec 31, 2019 |
| 10-K | Annual report | Apr 10, 2019 | Dec 31, 2018 |
| 10-K | Annual report | Apr 17, 2018 | Dec 31, 2017 |
| 10-K | Annual report | Mar 30, 2017 | Dec 31, 2016 |
| 10-K | Annual report | Mar 25, 2016 | Dec 31, 2015 |
| ARS | Annual report to shareholders | Apr 20, 2015 | Dec 31, 2014 |
| 10-K | Annual report | Mar 30, 2015 | Dec 31, 2014 |
| ARS | Annual report to shareholders | May 5, 2014 | Dec 31, 2013 |
| 10-K | Annual report | Mar 20, 2014 | Dec 31, 2013 |
| 10-K/A | Amended annual report | Apr 29, 2013 | Dec 31, 2012 |
| 10-K | Annual report | Mar 15, 2013 | Dec 31, 2012 |
| 10-K | Annual report | Mar 28, 2012 | Dec 31, 2011 |
| 10-K/A | Amended annual report | May 2, 2011 | Dec 31, 2010 |
| 10-K | Annual report | Mar 16, 2011 | Dec 31, 2010 |
| 10-K/A | Amended annual report | Apr 29, 2010 | Dec 31, 2009 |
| 10-K | Annual report | Mar 16, 2010 | Dec 31, 2009 |
| 10-K | Annual report | Mar 30, 2009 | Dec 31, 2008 |
| 10-K | Annual report | Mar 14, 2008 | Dec 31, 2007 |
| 10-K | Annual report | Mar 14, 2007 | Dec 31, 2006 |
| 10-K | Annual report | Mar 14, 2006 | Dec 31, 2005 |
Showing 28 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- OTLC (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Aguora Hills, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 908259
- Former names
- MATEON THERAPEUTICS INC (until Mar 26, 2021); OXIGENE INC (until Jun 3, 2016)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.